Sensus Healthcare Inc
NASDAQ:SRTS

Watchlist Manager
Sensus Healthcare Inc Logo
Sensus Healthcare Inc
NASDAQ:SRTS
Watchlist
Price: 8.89 USD -0.45% Market Closed
Market Cap: 145.7m USD
Have any thoughts about
Sensus Healthcare Inc?
Write Note

Sensus Healthcare Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sensus Healthcare Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Sensus Healthcare Inc
NASDAQ:SRTS
EPS (Diluted)
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
EPS (Diluted)
$5
CAGR 3-Years
-5%
CAGR 5-Years
9%
CAGR 10-Years
0%
Boston Scientific Corp
NYSE:BSX
EPS (Diluted)
$1
CAGR 3-Years
16%
CAGR 5-Years
9%
CAGR 10-Years
19%
Stryker Corp
NYSE:SYK
EPS (Diluted)
$9
CAGR 3-Years
23%
CAGR 5-Years
1%
CAGR 10-Years
19%
Abbott Laboratories
NYSE:ABT
EPS (Diluted)
$3
CAGR 3-Years
-7%
CAGR 5-Years
12%
CAGR 10-Years
10%
Intuitive Surgical Inc
NASDAQ:ISRG
EPS (Diluted)
$6
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
17%
No Stocks Found

Sensus Healthcare Inc
Glance View

Market Cap
145.7m USD
Industry
Health Care

Sensus Healthcare, Inc. operates as a medical device company, which provides treatments for both oncological and non-oncological skin conditions. The company is headquartered in Boca Raton, Florida and currently employs 37 full-time employees. The company went IPO on 2016-06-03. The firm is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The firm uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The firm incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100 Plus and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100 Plus offers remote diagnostics solutions, including operation tracking.

SRTS Intrinsic Value
10.46 USD
Undervaluation 15%
Intrinsic Value
Price

See Also

What is Sensus Healthcare Inc's EPS (Diluted)?
EPS (Diluted)
0.6 USD

Based on the financial report for Sep 30, 2024, Sensus Healthcare Inc's EPS (Diluted) amounts to 0.6 USD.

Back to Top